We have generated several lines of new evidence supporting a role for BPIFA1 and BPIFB1 in modulating the inflammatory response in CF, and have demonstrated that these molecules may contribute to CF severity through several complementary functions. This evidence concerns the gene BPIFB1 and cystic fibrosis.